Literature DB >> 17933487

Resection of liver metastases from non-colorectal non-endocrine primary tumours.

D Goéré1, D Elias.   

Abstract

Despite the greater number of hepatectomies for non-colorectal non-endocrine liver metastases, its benefits and its indications remain unclear because most of the patient series are small with heterogeneous primary tumours. After analyzing the literature including a large recent series (1451 patients), we can conclude that liver resection of non-colorectal non-endocrine metastases is feasible, safe, and improves survival. Better selection of patients according to their tumour biology (a long interval between the primary and liver metastases), the histologic type (non epithelial) and tumour chemosensitivity should improve long-term disease-free and overall survival, as we observed after resection of liver metastases from colorectal cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17933487     DOI: 10.1016/j.ejso.2007.07.205

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

1.  Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis.

Authors:  Michael D Staehler; Jessica Kruse; Nicolas Haseke; Thomas Stadler; Alexander Roosen; Alexander Karl; Christian G Stief; Karl W Jauch; Christiane J Bruns
Journal:  World J Urol       Date:  2010-05-04       Impact factor: 4.226

2.  Safety and prognostic role of regional lymphadenectomy for primary and metastatic liver tumors.

Authors:  Matteo Ravaioli; Giorgio Ercolani; Gian Luca Grazi; Matteo Cescon; Alessandro Dazzi; Chiara Zanfi; Antonio Daniele Pinna
Journal:  Updates Surg       Date:  2010-08

Review 3.  An unusual case of exclusive liver metastases from adenoid cystic carcinoma of the submandibular gland: a role for surgery? Report of a case.

Authors:  Genoveffa Balducci; Andrea Sagnotta; Mirko Muroni; Claudio Cacchi; Alberto D'Amato
Journal:  Surg Today       Date:  2011-03-23       Impact factor: 2.549

4.  Detection of liver metastases on gadobenate dimeglumine-enhanced MRI: systematic review, meta-analysis, and similarities with gadoxetate-enhanced MRI.

Authors:  Ling Zhang; Xian Yu; Lei Huo; Lun Lu; Xinpeng Pan; Ningyang Jia; Xinxiang Fan; Giovanni Morana; Luigi Grazioli; Guenther Schneider
Journal:  Eur Radiol       Date:  2019-03-26       Impact factor: 5.315

5.  A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases.

Authors:  Valérie Vilgrain; Maxime Esvan; Maxime Ronot; Aurore Caumont-Prim; Christophe Aubé; Gilles Chatellier
Journal:  Eur Radiol       Date:  2016-02-16       Impact factor: 5.315

Review 6.  Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature.

Authors:  Flavia Neri; Giorgio Ercolani; Paolo Di Gioia; Massimo Del Gaudio; Antonio Daniele Pinna
Journal:  Updates Surg       Date:  2015-08-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.